Published in Medical Letter on the CDC and FDA, October 30th, 2005
The company reports that patient identification has begun at several clinical trial sites, and that patient enrollment will begin immediately.
"The start of our phase II trial is a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.